Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial-Reference-Cited by-同舟云学术

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial

Published:2016-11 Issue:11 Volume:17 Page:1569-1578
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Yee Andrew J,Bensinger William I,Supko Jeffrey G,Voorhees Peter M,Berdeja Jesus G,Richardson Paul G,Libby Edward N,Wallace Ellen E,Birrer Nicole E,Burke Jill N,Tamang David L,Yang Min,Jones Simon S,Wheeler Catherine A,Markelewicz Robert J,Raje Noopur S

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer;Minucci;Nat Rev Cancer,2006

2. Histone deacetylase inhibitors: overview and perspectives;Dokmanovic;Mol Cancer Res,2007

3. Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma;Richardson;Leuk Res,2013

4. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma;Hideshima;Proc Natl Acad Sci USA,2005

5. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial;San-Miguel;Lancet Oncol,2014

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance;European Journal of Medicinal Chemistry;2024-05

2. Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives;Experimental Hematology & Oncology;2024-04-23

3. Central inhibition of HDAC6 re-sensitizes leptin signaling during obesity to induce profound weight loss;Cell Metabolism;2024-04

4. Autophagy-related mechanisms for treatment of multiple myeloma;Cancer Drug Resistance;2023-12-25

5. Design and synthesis of 1H-benzo[d]imidazole selective HDAC6 inhibitors with potential therapy for multiple myeloma;European Journal of Medicinal Chemistry;2023-12